Replies to post #26971 on Regen BioPharma Inc (RGBP)

[gotinearly]

Aplastic Anemia is the ODD and the approved US trial. This PR is referencing a use for HEMA for blood deficiencies due to Chemotherapy. Two completely different applications! This is huge news as the Drug is effective in other areas not just Aplastic Anemia...

i.e. Hema II, Hema III, etc.